Elite Pharma Inc (ELTP) financials · rev $148.9M
Elite Pharma Inc (ELTP) rev $148.9M.
| Line | FY2026 | FY2025 |
|---|---|---|
| Revenue | $148.9M | $84.0M |
| Cost of Revenue | $73.8M | $44.0M |
| Gross Profit | $75.0M | $40.1M |
| Operating Income | $49.1M | $19.6M |
| Net Income | $44.9M | -$4.3M |
| EPS (Diluted) | $0.03 | $0.00 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $138.3M | $96.4M |
| Current Assets | $112.1M | $57.7M |
| Cash & Equivalents | $29.8M | $11.3M |
| Inventory | $21.3M | $16.2M |
| PP&E | $10.2M | $10.3M |
| Total Liabilities | $39.4M | $42.9M |
| Current Liabilities | $17.4M | $11.8M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $98.9M | $53.5M |
| Retained Earnings | -$75.8M | -$120.7M |
| Line | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Operating Cash Flow | $23.7M | $7.5M | -$3.2M |
| CapEx | $925.6K | $1.6M | $0 |
| Investing Cash Flow | -$925.6K | -$2.4M | -$809.7K |
| Financing Cash Flow | -$4.3M | -$825.7K | $3.3M |
| Dividends Paid | $0 | $0 | $0 |
| Net Change in Cash | $18.5M | $4.2M | $0 |
| Free Cash Flow | $22.8M | $5.8M | $0 |
FAQ
What is ELTP P/E and revenue?
Elite Pharma Inc (ELTP) rev $148.9M.
What is ELTP revenue?
Elite Pharma Inc last cached revenue is $148.9M (FY2026).
Is ELTP profitable?
Elite Pharma Inc last cached net income is $44.9M.
What are ELTP total assets?
Elite Pharma Inc last cached total assets are $138.3M.
What is ELTP free cash flow?
Elite Pharma Inc last cached free cash flow is $22.8M.
Not investment advice. Cached statements, not a live tape.